PinnyPeptide

PTD-DBM vs SNAP-8

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

PTD-DBM

Cosmetic

Wnt-activating peptide that blocks CXXC5 — investigational topical hair-regrowth agent.

Peptide B

SNAP-8

Cosmetic

Eight-amino-acid SNARE-blocking peptide — topical "botox-alternative" for expression lines.

Typical vial

5 mg

Typical dose

Topical formulation-dependent mcg

Half-life

Variable; topical residence-time dependent

FDA status

Not FDA approved.

Typical vial

10 mg

Typical dose

5-10% topical concentration mcg

Half-life

Topical (residence time on skin)

FDA status

Cosmetic ingredient (not regulated as a drug).

PTD-DBM effects

  • Blocks CXXC5-Dvl interaction in hair follicles
  • Restores Wnt/β-catenin signaling
  • Promotes anagen (growth) phase reactivation
  • Synergistic with valproic acid in preclinical models
  • Investigational topical hair-regrowth agent

SNAP-8 effects

  • Competes with SNAP-25 in SNARE complex assembly
  • Reduces acetylcholine release at motor neuron terminals
  • Modest reduction in expression-line depth (topical)
  • Improvement in fine wrinkles around eyes and forehead
  • Stronger reported effect than parent Argireline at equivalent concentrations

PTD-DBM side effects

  • Limited human safety data
  • Theoretical: off-target Wnt activation in non-follicle tissues
  • Possible scalp irritation with topical use
  • Long-term safety in chronic use unstudied

SNAP-8 side effects

  • Topical: very low rate of irritation
  • Potential mild systemic absorption (effect unstudied)
  • Not formulated or tested for injection
  • Theoretical: systemic neuromuscular effects if injected (unstudied)

PTD-DBM dosing ranges

Topical hair regrowth research

Variable per formulation · Daily topical application to scalp · 12-24 weeks minimum for visible results

SNAP-8 dosing ranges

Topical anti-aging (cosmetic)

5-10% w/w in topical formulation · Once or twice daily · 8-12 weeks minimum for visible results

Full PTD-DBM guide → Full SNAP-8 guide →

PTD-DBM vs SNAP-8 — common questions

What is the difference between PTD-DBM and SNAP-8?

PTD-DBM: Wnt-activating peptide that blocks CXXC5 — investigational topical hair-regrowth agent. Typical dose Topical formulation-dependent mcg. SNAP-8: Eight-amino-acid SNARE-blocking peptide — topical "botox-alternative" for expression lines. Typical dose 5-10% topical concentration mcg. Both fall under the Cosmetic category.

Can you stack PTD-DBM and SNAP-8?

Stacking PTD-DBM with SNAP-8 is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, PTD-DBM or SNAP-8?

PTD-DBM is typically dosed: Daily topical application to scalp for Topical hair regrowth research. SNAP-8 is typically dosed: Once or twice daily for Topical anti-aging (cosmetic).

Are PTD-DBM and SNAP-8 FDA approved?

PTD-DBM: Not FDA approved. SNAP-8: Cosmetic ingredient (not regulated as a drug).

Related peptide comparisons

ghk-cu vs ptd-dbmmatrixyl vs ptd-dbmmelanotan-ii vs ptd-dbmpal-ghk vs ptd-dbmghk-cu vs snap-8matrixyl vs snap-8

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free